Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pegozafermin (1 trial)
bio89-100 (4 trials)
Fatty Liver (Phase 2)
Hypertriglyceridemia (Phase 2)
Liver Diseases (Phase 2)
Trials (5 total)
Trial APIs (2 total)